Director

Hirofumi Imai

A photo of Hirofumi Imai

Mr. Hirofumi Imai was the CEO of Fuji Pharma, a company based in Japan, for 18 years since 1998. Under his leadership, the company established itself as a market leader in the women's health market as well as in the diagnostic imaging market, and its EBITDA and market capitalization increased seven times and ten times, respectively. In 2012, the company got listed on the first section of the Tokyo Stock Exchange and also played a pivotal role in concluding the strategic partnership with Lotus Pharmaceuticals in 2019. Mr. Imai currently serves as the Chairman of Fuji Pharma.